SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001326732-24-000034
Filing Date
2024-06-13
Accepted
2024-06-13 08:05:23
Documents
15
Period of Report
2024-06-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xncr-20240613.htm   iXBRL 8-K 25268
2 EX-99.1 xncr-20240613xexx991.htm EX-99.1 12064
6 xencora.jpg GRAPHIC 6197
  Complete submission text file 0001326732-24-000034.txt   172763

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xncr-20240613.xsd EX-101.SCH 1898
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xncr-20240613_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xncr-20240613_pre.xml EX-101.PRE 12506
18 EXTRACTED XBRL INSTANCE DOCUMENT xncr-20240613_htm.xml XML 2728
Mailing Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107
Business Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

IRS No.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36182 | Film No.: 241040048
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)